CIK 0002028614 · <br>Emerging growth company
Drugs Made In America Acquisition Corp.
Sign in to watch- Ticker
- DMAA
- Exchange
- Nasdaq
- Industry
- Blank Checks
- FY end
- Dec 31
- Entity type
- operating
- Phone
- 646-726-7074
- Business address
- 420 LEXINGTON AVENUE, SUITE 1402, NEW YORK, NY, 10170
Securities
- DMAA Ordinary Shares Nasdaq
- DMAAR Rights Nasdaq
- DMAAU Units Nasdaq
- 8-K Event Material agreement · Other events
- 8-K Event Material agreement
- 10-Q Report Quarterly Report
- 8-K Event Material agreement
- 10-Q Report Quarterly Report
- 8-K Event Material agreement
- 8-K Event Bylaws or fiscal year change · Shareholder vote results · Other events
- 8-K Event Material agreement
- 10-K Report Annual Report
- 8-K Event Other events
- 8-K Event Material agreement · New debt or obligation · Other events
- 8-K Event Other events
- 8-K Event Executive or director change
- 10-Q Report Quarterly Report
- 8-K Event Executive or director change
- 10-Q Report Quarterly Report
- 10-Q Report Quarterly Report
- 10-K Report Annual Report
- 8-K Event Unregistered share sale · Other events
- 8-K Event Other events
Page 1 of 2 · 22 filings